baber/WOPTO huggingface dataset:
Patent EP-1027410-A1 (EP)
Inventor: AHMED IRSHAD
IPC: C10L1/195
Filed: 1998-10-19
Abstract: L'invention concerne un additif polymère pour carburant, un procédé de fabrication dudit additif et un carburant renfermant cet additif. L'additif s'obtient par mélange isotherme d'un alcool ethoxylé et d'un amide, l'alcool ethoxylé renfermant, en poids, au moins 75 % d'au moins un alcool linéaire à chaîne droite ayant une longueur de chaîne hydrocarbonée d'environ neuf à environ quinze atomes de carbone et l'amide s'obtenant par réaction d'un alcool-amine avec une quantité équimolaire d'un alkyle-esther d'un acide gras ou dérivé. L'additif polymère est obtenue par mélange isotherme de la composition alcool/amide à une quantité sensiblement équimolaire d'un acide gras d'ethoxylé ayant une longueur de chaîne hydrocarbonée d'environ neuf à environ quinze atomes de carbone. Le procédé de l'invention consiste en un brassage lent et régulier destiné à éviter une dégradation moléculaire de l'additif.
Patent EP-1009306-A1 (EP)
Inventor: MUELLER GERHARD
IPC: A61B18/12
Filed: 1998-09-04
Abstract: An electrode arrangement is provided having at least one electrode for insertion into a human or animal body for electrothermal treatment of the body. The electrode is situated on an electrode support and is connected to an alternating current source via a supply lead and to a temperature stabilizer device for influencing the effective temperature profile in a treatment area. The electrode support and the electrode, or electrodes, are constructed for direct insertion into body tissue, said insertion being channel forming. The temperature stabilizer device has a timed heating device.
Patent EP-1028962-A1 (EP)
Inventor: CAMA LOVJI D
IPC: C07D519/00
Filed: 1998-10-19
Abstract: Compounds of formula (I) are disclosed as well as pharmaceutically acceptable salts thereof. The naphthosultam is substituted with various substituent groups including at least one cationic group -A-Q-L-B. The carbapenems of the invention are effective against susceptible bacterial organisms, including methicillin resistant Staphylococcus aureus (MRSA), methicillin resistant Staphylococcus epidermidis (MRSE), and methicillin resistant coagulase negative Staphylococci (MRCNS).
Patent EP-0958648-A1 (EP)
Inventor: HEERINGA SCHELTE
IPC: H02M7/217
Filed: 1998-11-30
Abstract: A switched-mode power supply uses duty cycle control (18) for the switching transistor (6). The primary current through the primary winding (2) is sensed by means of a sensing resistor (8) in series with the switching transistor (6). The voltage across the sensing resistor (8) is differentiated (30, 32), compared (36) with a reference (38) and integrated (40). The integrated signal lengthens the off period of the switching transistor (6), thereby limiting the peak value of the primary current at the beginning of the on period of the switching transistor (6). The peak value of the primary current at the end of the on period is limited by sensing (20) the voltage across the sensing resistor (8). The combined limitations of the primary current ensure that the output current of the switched-mode power supply is limited in a well-defined manner.
Patent EP-1025510-A1 (EP)
Inventor: VAUGHAN PAUL WILLIAM
IPC: G06N5/00
Filed: 1998-10-22
Abstract: Dans des modes de réalisation de l'invention, on utilise une technique permettant d'écrire des programmes de retour arrière dans un langage informatique universel (par exemple C++ ou Java) sans que la structure de commande du programme n'ait à refléter la structure de l'arbre de décision. Etant donné qu'il n'est pas nécessaire que la structure de commande du programme de recherche possède la même forme que l'arbre de décision, il n'est pas nécessaire que continue d'exister une partie commande état, destinée au point de décision voulu, sur la pile d'exécution (504); ainsi le point de détection d'erreur (507) peut n'être pas directement associé au point voulu, mais tout simplement précéder celui-ci. La partie restante de la commande état est restaurée par une réexécution du programme dans un mode spécial de réexécution, jusqu'à l'obtention de l'état voulu, et une autre variante peut être choisie.
Patent EP-0991126-A1 (EP)
Inventor: YASUKAWA MASAHIRO
IPC: G02F1/136
Filed: 1998-12-04
Abstract: In production of a semiconductor device using an SOI
technology by an adhering method, a thin film with high
thermal conductivity is formed between an insulating
supporting substrate and a single-crystal silicon film
formed thereon to enhance uniformity of a thermal
distribution. The single-crystal silicon film is subjected
to thermal treatment to improve uniformity of the thermal
distribution and to enhance the adhering strength during an
adhering step. When a peripheral circuit provided with
switching elements showing a large amount of heat generation
is formed of semiconductor devices having a thin film with
high thermal conductivity to enhance the heat dissipating
function, temperature rise during the operation is
suppressed. When the thin film with high thermal
conductivity is composed of a light shielding material, the
light shielding function is also improved. Accordingly,
temperature rise and deterioration of the characteristics of
the switching element due to incident light can be
suppressed.
Patent EP-1038231-A1 (EP)
Inventor: PAWLOWSKI STEPHEN S
IPC: G06F13/26
Filed: 1998-11-02
Abstract: One embodiment of the invention includes an apparatus (10), such as a bridge, for use in connection with computer system. The apparatus includes remote priority capture logic (32) to hold task priority data indicative of a task priority of each processor P0 in the computer system that is available for lowest priority interrupt destination arbitration (LPIDA). The apparatus also includes lowest priority logic (42) to perform the LPIDA to select processor in the computer system is to receive an interrupt message based on contents of the remote priority capture logic (32). Another embodiment of the invention includes a multi-processor system having processors and a processor bus (18) coupled to the processors (P0, P1, P2, P3). The system includes remote priority capture logic (32) to hold task priority data indicative of a task priority of the processors while they are available for lowest priority interrupt destination arbitration (LPIDA). The system also includes lowest priority logic (42) to perform the LPIDA to select processors (P0, P1, P2, P3) is to receive an interrupt message based on contents of the remote priority capture logic (32), the interrupt message being provided to the processor through the processor bus (18).
Patent EP-1030874-A1 (EP)
Inventor: OATES JOHN D
IPC: C08J5/18
Filed: 1998-11-12
Abstract: A film-forming, aqueous dispersion comprising at least one substantially random interpolymer comprising (A) polymer units derived from: (1) at least one vinylidene aromatic monomer, or (2) at least one hindered aliphatic or cycloaliphatic vinylidene monomer, or (3) a combination of at least one aromatic vinylidene monomer and at least one hindered aliphatic or cycloaliphatic vinylidene monomer, and (4) at least one C2-20 α-olefin; and (B) a surfactant. The aqueous dispersions or emulsions of the present invention are useful as barrier paper coatings, corrosion resistance coatings, carpet backing and carpet fiber binders, in some instances, precursors for high molecular weight polymers, composites and membranes for separation systems, coatings and binders for paints, inks, moisture barriers in packaging, fabric coatings, synthetic gloves, adhesives, foams, composite flooring tiles and layers, sound deadening composite foams and pads, automotive protective exterior coatings, and removable temporary protective coatings.
Patent EP-1035886-A1 (EP)
Inventor: CONNELL DONALD G
IPC: A61M16/08
Filed: 1998-11-24
Abstract: L'invention concerne une canule oro/nasopharyngienne (30, 50, 70, 80) comprenant un élément tubulaire arqué (38, 52, 70, 80) destiné à être inséré dans le pharynx d'un patient (12) par la bouche ou par le nez, de manière à empêcher l'obstruction des ces voies en cours d'anesthésie. En mode de réalisation préféré, un gaz d'inhalation, généralement de l'oxygène (O2), est envoyé dans la canule(30, 50, 70, 80) via une conduite de gaz (32, 60, 78, 82) reliée à l'extrémité proximale (80B) de l'élément tubulaire (38, 52, 70, 80), tandis que du dioxyde de carbone expiré (CO2) est échantillonné dans le pharynx du patient via une seconde conduite de gaz (34, 62, 79, 84) reliée audit élément (38, 52, 70, 80), à proximité de son extrémité distale (80A). De préférence, les conduites respectives d'inhalation et d'expiration sont placées à l'intérieur de l'élément tubulaire (38, 52, 70, 80), dont elles font partie intégrante. L'invention concerne également un dispositif conçu pour être utilisé avec une canule oro/nasopharyngienne classique (30, 50, 70, 80), de manière à acheminer un gaz d'inhalation vers une extrémité proximale (80B) d'une canule mécanique et à échantillonner le gaz d'expiration à une extrémité distale (80A) de ladite canule (30, 50, 70, 80).
Patent EP-1045888-A1 (EP)
Inventor: ABE HIDETOSHI
IPC: C09J7/38
Filed: 1998-12-21
Abstract: Le problème auquel on est confronté dans l'art concerne la production d'une feuille adhésive qui peut conserver une structure irrégulière spécifique juste après le collage sur un support adhérent de sorte que des bulles puissent efficacement s'échapper même lorsque ces dernières sont piégées, et qu'ensuite la structure irrégulière se déforme pour que la détérioration de l'aspect n'existe plus après le collage. Pour résoudre ce problème, une feuille adhésive comprend un film de substrat souple; une couche adhésive qui se trouve en contact avec une surface principale de la feuille de substrat et qui présente une structure irrégulière comportant des parties saillantes destinées à se trouver en contact avec un support adhérent et des rainures qui sont formées entre les parties saillantes adjacentes et qui sortent à l'extérieur lorsque les parties saillantes sont en contact avec le support adhérent; et une protection qui présente une structure inverse correspondant à la structure irrégulière de la couche adhésive et qui est pressée sur la couche adhésive pour que la structure inverse et la structure irrégulière située sur la couche adhésive soient en contact l'une avec l'autre. La couche adhésive comprend un polymère réticulé et conserve la structure irrégulière juste après le collage de la feuille adhésive sur le support adhérent, puis la structure irrégulière se déforme et la surface de contact augmente jusqu'à atteindre 92 %, ou bien la couche adhésive comprend un composant de matrice contenant un polymère adhésif et des microsphères élastiques qui sont dispersées dans ledit composant de matrice et dont le diamètre en volume moyen se situe entre 10 et 100 νm.
Patent EP-0937525-A1 (EP)
Inventor: DAMM NORBERT
IPC: B22D27/11
Filed: 1999-02-17
Abstract: The melt volume forced upwards during closure of the riser pipe (7) and cut-off of the melt column is pressed into the sprue (11) of the casting die. The apparatus includes a closure unit whose motion directly closes the riser pipe.
Patent EP-0940946-A1 (EP)
Inventor: MOMONA MORIHISA
IPC: G06F13/00
Filed: 1999-03-05
Abstract: In a communication network where IEEE-1394 nodes are connected to
a serial bus, each node functions as a source or a destination for signaling an
asynchronous channel setup request containing a multicast address and
signaling an asynchronous channel release request. A multicast manager,
connected to the bus, includes a channel allocation table having a number of
entries each mapping a channel number to a multicast address. The multicast
manager responds to the setup request for making a search through the
allocation table, setting a node count value to 1, acquiring ownership of a
channel number from an isochronous resource manager and mapping the
acquired channel number to the multicast address of the request in a
corresponding entry of the allocation table if no channel number was mapped
to the multicast address or incrementing the node count value by 1 if a
channel number is mapped to the multicast address, and then signaling a reply
message. The source node responds to this reply message by multicasting
asynchronous stream packets to the serial bus. The multicast manager further
responds to the asynchronous channel release request for decrementing the
node count value by 1. When the node count value equals zero, the
ownership of the channel number is restored to the isochronous resource
manager and the corresponding entry of the channel allocation table is
cleared.
Patent EP-0943921-A1 (EP)
Inventor: JUNGKUNZ CLEMENS DIPL-ING
IPC: B61F5/22
Filed: 1999-03-08
Abstract: Das Verfahren bzw. die Vorrichtung betrifft die Bestimmung einer näherungsweisen Geschwindigkeit eines schienengebundenen Fahrzeuges. Zwei Signale, welche geometrische Eigenschaften bzw. Unebenheiten der Gleisstrecke wiedergegeben, werden an zwei Meßorten, die einen Abstand L aufweisen, aufgenommen. Die Sensoren sind beispielsweise Beschleunigungssensoren und erzeugen zwei Signale S1 und S2. Ein geschätzter Geschwindigkeitswert wird durch eine Laufzeitkorrelation an seinen tatsächlichen Wert angenähert. Hierzu wird ein verzögertes Signal S0 dadurch erzeugt, daß das Signal S1 wird mit einer Zeitverzögerung versehen wird, welche aus dem aktuell geschätzten Geschwindigkeitswert abgeleitet wird. Die Differenz S2 - S0 wird mit der Abteilung von S2 + S0 multipliziert und ergebt ein Regelsignal, mit dem ein neuer Wert für die geschätzte Geschwindigkeit bestimmt wird. <IMAGE>
Patent EP-1054055-A1 (EP)
Inventor: NELLES GABRIELE DR
IPC: C12Q1/02
Filed: 1999-05-19
Abstract: The invention relates to a method for providing a substrate structure for oriented neuron
growth, wherein a basic substrate is provided, characterized in that at least one alignment
layer is deposited on said substrate and a mono- or multi-layer of a liquid crystal material is
deposited on said at least one alignment layer or a combined alignment layer comprising
liquid crystal material is deposited on said basic substrate, thereby providing a structured
surface.
Patent EP-1057522-A1 (EP)
Title: Method for manufacturing/handling fluid component packaged goods, manufacture/handling instructing data code for use in this method and fluid component packaged goods affixed by this manufacture/handlung instructing data code
Inventor: TAKADA HIROMICHI
IPC: B01F13/10
Filed: 1999-05-31
Abstract: There is provided a method for manufacturing and handling
a variety of fluid component packaged goods efficiently.
Fluid component is prepared within a packaging container and
a manufacturing/handling instructing data code containing
both manufacturing information of the fluid component and
handling information of the fluid component packaged goods
is indicated on the package to carry out the whole
manufacturing and handling steps from first to last by the
data code.
Patent EP-0954182-A1 (EP)
Inventor: SUZUKI TERUHIKO
IPC: H04N19/51
Filed: 1994-03-01
Abstract: Mismatch error occur in the local decoder (10) of a MPEG-standard compressor for a motion picture
signal, and in an MPEG-standard expander (34) for a compressed motion picture signal. This is because of
the lack of a standard for rounding results of *.5 (* is an integer) obtained when a set of transform
coefficients resulting from compressing the motion picture signal is inversely orthogonally
transformed. The invention prevents mismatch errors by preprocessing (14) the set of transform
coefficients prior to the inverse orthogonal transform. The transform coefficients in the set are
summed (23A), and the parity (odd or even) of the sum is judged (21). When the parity of the sum is judged to
be even, the parity of one of the transform coefficients in the set is inverted (28) to provide a parity-inverted
transform coefficient. This makes the parity of the sum odd. Then, when the set of
transform coefficients including the parity-inverted transform coefficient is inversely othogonally
transformed (15), none of the results of the orthogonal transform will have a value of *.5.
Patent EP-0974458-A1 (EP)
Inventor: BORGMANN ROB
IPC: B41M1/34
Filed: 1999-07-16
Abstract: A rotating hollow screen template (2) is used with a print surface whose width is at least as wide as the greatest width of the objects to be printed. Following the printing process the ink remaining on the rollers is mechanically removed. An arrangement for carrying out the printing process is also claimed.
Patent EP-0974541-A1 (EP)
Inventor: DRAGHETTI FIORENZO
IPC: B65B19/02
Filed: 1999-07-20
Abstract: A device (7) for splicing strips of thermoplastic
material to splice a first strip (5a) extending along a
first path (Pa) and a second strip (5b) extending along
a second path (Pb); the device having first guides (18)
for guiding the first strip (5a), and second guides (14)
for guiding the second strip (5b), the first and second
guides (18,14) being movable with respect to each other
to bring together a portion (61) of the first strip (5a)
and a portion (60) of the second strip (5b); a heat-seal
block (48) movable between a rest position and a work
position to grip and heat seal the portions (61,60) of
the first and second strips (5a,5b) between the heat-seal
block and the second guides (14); and a heatable
element (55) which is movable to intercept a portion of
at least one of the first and second strips (5a,5b) and
cut the strip (5a,5b) by melting the portion of the
strip (5a,5b) contacting the element (55).
Patent EP-0980881-A1 (EP)
Inventor: IRLE CHRISTOPH DR
IPC: C09D175/04
Filed: 1999-08-04
Abstract: The use of an aqueous dispersion of a polyol component, comprising 20-60 wt.% unsaturated polyester polyol and 40-80 wt.% polyacrylate, and 1-70 wt.% (with respect to total solids) of a blocked aliphatic polyisocyanate component for light-stable, elastic, physically fast-drying coatings in series lacquering of cars is claimed. The use of an aqueous dispersion of (A) a polyol component and (B) a polyisocyanate component for light-stable, elastic, physically fast-drying coatings in series lacquering of cars is claimed. The polyol component comprises 20-60 wt.% polyester component (AI) with 10-60 wt.% units derived from 8-30 carbon (C) aliphatic (un)saturated monocarboxylic acid(s) and 0.4-5 wt.% units derived from 3-8 C  alpha , beta -unsaturated mono- or dicarboxylic acid(s) or anhydride(s) capable of free radical polymerization and 40-80 wt.% polyacrylate component (AII). The polyisocyanate component (B) comprises blocked aliphatic polyisocyanate(s) and is used in an amount of 1-70 wt.% with respect to total solids in the dispersion.
Patent EP-1088483-A1 (EP)
Inventor: GERSTAEDT PETER DR
IPC: A23K10/16
Filed: 1999-09-30
Abstract: A food concentrate for dairy cattle, milk goats, calves and young beef cattle consist of a sweet-flavored Yucca palm extract, active and inactive yeast combined with a suitable substrate. A farm animal food concentrate additive consists of a sweet flavored plant extract such as Yucca palms, together with an active yeast , an inactive yeast and a substrate. The concentrate also contains a micro-biological additive especially Saccharomyces serevisiae IP 1077 at a concentration of 5 x 10(9 KBE/kg total weight. The concentrate also contains trace elements copper (68 mg/kg), selenium (100 mg/kg) or cobalt (80 mg/kg). In lieu of the inactive yeast the mixture may contain vitamins A (5,900 I.E./kg), D3 (1,350 I.E.(kg) or E (10,000 mg/kg). The concentrate also contains an emulsifier such as lutein and tartracin.
Patent EP-1022481-A1 (EP)
Inventor: SCHOO NORBERT DR
IPC: F16D69/02
Filed: 1999-11-15
Abstract: A friction face coating comprises (by wt.) 0-30 % phenolic resin, 5-95 % aluminum oxide, 0-20 % silicon oxide, 5-75 % adhesive, 0-10 % wetting agent, 0-50 % elastomer and 0-50 % filler.  An Independent claim is also included for a brake lining, especially a disk brake, comprising a backing plate bearing a friction material block, on the friction face of which the above friction face coating is provided. Preferred Features: The coating also contains 20-80 (especially 50) wt.% solvent, especially water. The coating has the composition (by wt.) (a) 3% phenolic resin, 54.8% aluminum oxide, 3.2% silicon oxide, 38% adhesive and 1% wetting agent; (b) 56.49% aluminum oxide, 3.3 % silicon oxide, 39.18% adhesive and 1.03% wetting agent; (c) 49.12% aluminum oxide, 2.87 % silicon oxide, 34.07% adhesive, 0.9% wetting agent and 13.04% elastomer; or (d) 41.99-31.99 % aluminum oxide, 10-20% silicon oxide, 34.07% adhesive, 0.9% wetting agent and 13.04% elastomer.
Patent EP-0991165-A1 (EP)
Inventor: RIST OTTO
IPC: H01F5/00
Filed: 1998-07-03
Abstract: The device for producing coils and coil groups has at least two stages (5-8) of a part of the winding template (4) formed opposing each other. All stages are telescopic. Operating devices for all stages are provided.
Patent EP-1002475-A1 (EP)
Inventor: ELLIS FRAMPTON E III
IPC: A43B5/00
Filed: 1993-08-10
Abstract: Footwear, particularly for athletic shoes, that has a sole structure (28) copying the
underlying support, stability and cushioning structures of the human foot. Still more
particularly, this invention relates to the use of relatively flexible and inelastic fiber (155a,
182) within the material of the shoe sole to provide both flexibility and firmness under load-bearing
pressure. It also relates to the use of sipes, particularly those that roughly parallel the
foot sole of the wearer in frontal plane cross sections (152, 181), contained within the she sole
under the load-bearing structures of the wearer's foot to provide the firmness and flexibility to
deform to flatten under weight-bearing loads in parallel with the wearer's foot sole. Finally,
it relates to providing additional shoe sole width (figures 19-22) to support those areas
identified as mandatory to maintaining the naturally firm lateral support of the wearer's foot
sole during extreme sideways motion while load-bearing.
Patent EP-1106185-A1 (EP)
Inventor: SCHRAA EDWIN OSCAR
IPC: A61K48/00
Filed: 1999-12-08
Abstract: A method of reducing the risk associated with
administering adenoviral particles to subjects undergoing
adenoviral gene therapy. An extremely low titer of
adenovirus neutralizing antibodies is believed to lead to the
an acute virus-mediated cytotoxicity. Neutralizing antibodies
prevent the hepatotoxic effects of adenoviruses administered
by way of the hepatic artery. An improved adenoviral gene
therapy method of the type involving the administration, at a
certain point in time, of recombinant adenoviruses containing
a gene of interest to a subject wherein the improvement
includes, before administering the recombinant adenovirus
containing the gene of interest, providing the subject with
neutralizing antibodies directed to the recombinant
adenovirus. In one aspect of the method, the subject is
provided with the antibodies by administering to the subject
adenovirus of the same type as the recombinant adenovirus to
be administered, at a before the administration of the
recombinant adenovirus, to induce in the subject an immune
response against the adenovirus. Alternatively, when
insufficient time exists, or the subject is
immunocompromised, the subject is directly provided with the
neutralizing antibodies by administering, to the subject,
antibodies directed against the same serotype of adenovirus
as the recombinant adenovirus or antibodies cross-reactive
with the serotype of the recombinant adenovirus. In such a
case, the antibodies are administered about one hour before
the administration of the recombinant adenovirus containing
the gene of interest. In this aspect of the invention,
human antibodies or humanized antibodies are particularly
preferred to be administered parenterally to the subject.